Text Size:

COMPASS US | International

THE CYPASS® MICRO-STENT


A glaucoma micro-stent for cataract patients
Transcend Medical has developed micro-stent technology that is designed to be implanted at the time of cataract surgery in patients with primary open-angle glaucoma. About 20% of patients undergoing cataract surgery have a concurrent diagnosis of glaucoma – in the US, this leads to over 700,000 patients per year who could benefit from combined therapy.